NPI: 1396059382 · CARROLLTON, AL 35447 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 08/02/2010
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 08/02/2010 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 5,469 | $153K |
| 2019 | 8,645 | $194K |
| 2020 | 5,174 | $131K |
| 2021 | 1,153 | $15K |
| 2022 | 1,539 | $25K |
| 2023 | 730 | $14K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 10,145 | 753 | $365K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 6,887 | 361 | $161K |
| J1756 | Injection, iron sucrose, 1 mg | 545 | 140 | $3K |
| J1270 | Injection, doxercalciferol, 1 mcg | 4,234 | 331 | $2K |
| 83970 | 83 | 73 | $852.18 | |
| A4657 | Syringe, with or without needle, each | 173 | 149 | $297.00 |
| 85041 | 215 | 172 | $128.96 | |
| 85048 | 215 | 172 | $120.00 | |
| 83550 | 51 | 49 | $117.70 | |
| 82728 | 54 | 49 | $112.10 | |
| 83540 | 51 | 49 | $77.30 | |
| 82108 | 13 | 12 | $74.94 | |
| 85045 | 26 | 25 | $29.50 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 18 | 12 | $0.00 |